Table 4 New onset comorbid conditionsa, stratified by last observed biochemical control
From: The association between biochemical control and cardiovascular risk factors in acromegaly
Controlled N = 79; 65.8% | Uncontrolled N = 41; 34.2% | All N =120 | ||
|---|---|---|---|---|
Cardiovascular | ||||
Hypertension | n | 6 | 3 | 9 |
(%) | (7.6) | (7.3) | (7.5) | |
Diabetes mellitus | n | 3 | 4 | 7 |
(%) | (3.8) | (9.8) | (5.8) | |
Left ventricular hypertrophy | n | 7 | 2 | 9 |
(%) | (8.9) | (4.9) | (7.5) | |
Cardiomyopathy or heart failure | n | 0 | 0 | 0 |
(%) | (0.0) | (0.0) | (0.0) | |
Other | ||||
Sleep apnea | n | 0 | 0 | 0 |
(%) | (0.0) | (0.0) | (0.0) | |
Colonic polyps or colon cancer | n | 1 | 1 | 2 |
(%) | (1.3) | (2.4) | (1.7) | |
Visual field defects | n | 6 | 2 | 8 |
(%) | (7.6) | (4.9) | (6.7) | |